Nonalcoholic Steatohepatitis (NASH)

What is Nonalcoholic Steatohepatitis (NASH)? Understanding Progressive Liver Inflammation Without Alcohol Use

Nonalcoholic Steatohepatitis (NASH) is a serious and progressive form of Nonalcoholic Fatty Liver Disease (NAFLD), characterized by liver inflammation and cell damage due to fat accumulation in the liver — in individuals who consume little to no alcohol. Unlike simple fatty liver, NASH can lead to liver fibrosis (scarring), cirrhosis, liver failure, and even liver cancer.

NASH is most commonly found in people who are overweight, diabetic, or have high cholesterol or metabolic syndrome. However, it often goes undetected due to a lack of symptoms in early stages. With rising obesity and diabetes rates, NASH is becoming one of the leading causes of liver transplants worldwide.

Symptoms of NASH

NASH is often called a “silent” disease because many people don’t experience symptoms until the condition becomes severe. However, as liver damage progresses, symptoms may include:

  • Chronic Fatigue: Feeling tired or low energy, even with rest

  • Right Upper Abdominal Discomfort: A dull or persistent pain near the liver

  • Unexplained Weight Loss: Often seen in more advanced disease

  • Swelling or Jaundice: In late stages, fluid buildup, yellowing of the skin or eyes may occur

  • Mental Confusion: Severe liver dysfunction can affect brain function (hepatic encephalopathy)

Routine blood tests or imaging studies often reveal elevated liver enzymes, which may lead to further evaluation and diagnosis.

Diagnosing Nonalcoholic Steatohepatitis

Early and accurate diagnosis of NASH is critical to slowing disease progression and avoiding irreversible liver damage. Diagnostic tools include:

  • Blood Tests: To check for elevated liver enzymes and rule out other causes of liver disease

  • Imaging: Ultrasound, MRI, or FibroScan can detect liver fat and stiffness

  • Liver Biopsy: The gold standard to confirm NASH and assess the degree of inflammation and fibrosis

  • Non-Invasive Fibrosis Scoring: Clinical research often uses advanced diagnostic scoring to monitor disease progression

Clinical research centers like BioResearch Partner may also use specialized tools and biomarkers to assess liver function and inflammation without invasive procedures.

Current Treatments for NASH

There are currently no FDA-approved medications specifically for NASH, making it an active area of clinical research. Current management strategies include:

  • Weight Loss: Losing 7–10% of body weight is shown to reduce liver inflammation and fibrosis

  • Dietary Changes: Adopting a Mediterranean-style diet low in sugar and saturated fats

  • Exercise: Regular activity to improve insulin sensitivity and reduce fat buildup

  • Blood Sugar and Cholesterol Control: Managing associated metabolic conditions

  • Avoiding Liver Stressors: Including alcohol and unnecessary medications

Advanced disease may require a liver transplant, highlighting the urgency of developing effective medical therapies.

The Role of Clinical Research in NASH Treatment

As a leading cause of chronic liver disease, NASH has become a priority for pharmaceutical research. Clinical trials are essential to test new therapies aimed at reversing liver damage, reducing inflammation, and preventing complications.

Benefits of Participating in Clinical Research:

  • Access to Innovative Therapies: Participate in trials evaluating medications before they become widely available

  • Comprehensive Health Monitoring: Frequent labs, imaging, and expert assessments

Contribute to Future Breakthroughs: Help advance medical knowledge and improve care for NASH patients everywhere

How BioResearch Partner Supports NASH Research

At BioResearch Partner, we collaborate with hepatologists, endocrinologists, and leading research institutions to bring high-quality NASH studies to the Miami area. We ensure that studies are safe, efficient, and patient-focused.

Why Choose BioResearch Partner?

  • Expert Clinical Staff: Dedicated coordinators guide each participant through the process

  • High-Standard Protocols: Focused on patient safety, comfort, and precision

  • Inclusive and Diverse Enrollment: Ensuring trials reflect real-world populations and needs

Our team works to make clinical trial participation a supportive and empowering experience for every volunteer.

Participate in a Clinical Trial and Help Shape the Future of Liver Disease Care

If you or a loved one has been diagnosed with NASH, clinical research may offer access to promising new treatments and personalized care. At BioResearch Partner, we are currently enrolling participants in NASH studies and helping shape the future of liver disease management.

📞 Call: 833-489-4978
🌐 Visit: www.bioresearchpartner.com
📩 Email: info@bioresearchpartner.com

Become a BioResearch Partner

Our associates eagerly anticipate your communication. Please feel free to contact us at your earliest convenience to arrange a meeting and obtain further information. Alternatively, you may complete our form, and we will promptly reach out to provide the requested information.